Tue, 30 Nov 2010 15:59:25 -0500
Alliance for Human Research Protection
A Catalyst for Debate
www.ahrp.org
FYI

The instances in the letter involve ghostwriting by only one company--Scientific Therapeutics Information (STI)-- and involve only one drug--GlaxoSmithkline's (GSK) antidepressant, Paxil.
Duff Wilson of The New York Times reports that previously sealed GlaxoSmithKline documents reveal that a textbook in psychiatry, whose listed authors are Charles Nemeroff, MD and Alan Schatzberg, MD, was actually ghostwritten by Sally Laden of STI.
GSK paid the ghostwriter and the "authors" who penned their names to the book.
The sheer audacity prompted former FDA commissioner, Dr. David Kessler to exclaim: "To ghostwrite an entire textbook is a new level of chutzpah. "I've never heard of that before. It takes your breath away."
Surely that is a dubious distinction in academic medicine!
Read much more... http://www.ahrp.org/cms/content/view/738/9/
Contact: Vera Hassner Sharav
veracare@ahrp.org
212-595-8974
No comments:
Post a Comment